Soleno Therapeutics (SLNO) Debt Ratio (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Debt Ratio of 0.08 for Q1 2026, down 47.68% year-over-year from 0.16 in Q1 2025, and down 7.31% quarter-over-quarter from 0.09 in Q4 2025.
Soleno Therapeutics (SLNO) Debt Ratio (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Debt Ratio for 5 consecutive years, with 0.08 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio fell 47.68% year-over-year to 0.08; the TTM figure through Mar 2026 stood at 0.08 (down 47.68% YoY), while the FY2025 annual figure was 0.09, down 41.26% from the prior year.
- Debt Ratio declined to 0.08 in Q1 2026 per SLNO's latest filing, from 0.09 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.16 in Q1 2025 and bottomed at 0.08 in Q1 2026.
- Historically, Debt Ratio has averaged 0.12 across 3 years, with a median of 0.12 in 2025.
- Annual changes were most pronounced in 2025 — Debt Ratio plunged 41.26% — and 2026, when it sank 47.68%.
- Soleno Therapeutics' Debt Ratio stood at 0.15 in 2024, then slumped by 41.26% to 0.09 in 2025, then declined by 7.31% to 0.08 in 2026.
- Business Quant data shows SLNO's Debt Ratio at 0.08 in Q1 2026, 0.09 in Q4 2025, and 0.08 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.15 |
| Dec 31, 2014 | 0.01 |
| Dec 31, 2013 | 8.82 |